ADVERSE-EFFECTS FROM METOPROLOL ARE NOT GENERALLY ASSOCIATED WITH OXIDATION STATUS

被引：27

作者：

CLARK, DWJ ^{[1
]}

MORGAN, AKW ^{[1
]}

WAALMANNING, H ^{[1
]}

机构：

[1] UNIV OTAGO,SCH MED,WELLCOME MED RES INST,DEPT MED,DUNEDIN,NEW ZEALAND

来源：

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1984年 / 18卷 / 06期

关键词：

D O I：

10.1111/j.1365-2125.1984.tb02573.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：965 / 967

页数：3

共 7 条

[1] ANTIPYRINE METABOLISM IN RELATION TO POLYMORPHIC OXIDATIONS OF SPARTEINE AND DEBRISOQUINE [J].

EICHELBAUM, M ;

BERTILSSON, L ;

SAWE, J .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 15 (03) :317-321

[2] DEFECTIVE N-OXIDATION OF SPARTEINE IN MAN - NEW PHARMACOGENETIC DEFECT [J].

EICHELBAUM, M ;

SPANNBRUCKER, N ;

STEINCKE, B ;

DENGLER, HJ .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 16 (03) :183-187

[3]

IDLE JR, 1983, LANCET, V1, P1388

[4]

LENNARD MS, 1983, NEW ENGL J MED, V308, P965

[5] DEFECTIVE METABOLISM OF METOPROLOL IN POOR HYDROXYLATORS OF DEBRISOQUINE [J].

LENNARD, MS ;

SILAS, JH ;

FREESTONE, S ;

TREVETHICK, J .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 14 (02) :301-303

[6] OXIDATION PHENOTYPE - A MAJOR DETERMINANT OF METOPROLOL METABOLISM AND RESPONSE [J].

LENNARD, MS ;

SILAS, JH ;

FREESTONE, S ;

RAMSAY, LE ;

TUCKER, GT ;

WOODS, HF .

NEW ENGLAND JOURNAL OF MEDICINE, 1982, 307 (25) :1558-1560

[7] IMPAIRED OXIDATION OF DEBRISOQUINE IN PATIENTS WITH PERHEXILINE NEUROPATHY [J].

SHAH, RR ;

OATES, NS ;

IDLE, JR ;

SMITH, RL ;

LOCKHART, JDF .

BRITISH MEDICAL JOURNAL, 1982, 284 (6312) :295-299

← 1 →